RLBP1
Retinaldehyde-binding protein 1
Also known as: CRALBP, RLBP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P12271
- Gene
- RLBP1
- Ensembl
- ENSG00000140522
- Chromosome
- 15
- Canonical length
- 317 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Centrosome,Cytosol
OverviewNCBI Gene
The protein encoded by this gene is a 36-kD water-soluble protein which carries 11-cis-retinaldehyde or 11-cis-retinal as physiologic ligands. It may be a functional component of the visual cycle. Mutations of this gene have been associated with severe rod-cone dystrophy, Bothnia dystrophy (nonsyndromic autosomal recessive retinitis pigmentosa) and retinitis punctata albescens. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
317 residues, UniProt reviewed canonical sequence.
>P12271|RLBP1
1 MSEGVGTFRM VPEEEQELRA QLEQLTTKDH GPVFGPCSQL PRHTLQKAKD ELNEREETRE
61 EAVRELQEMV QAQAASGEEL AVAVAERVQE KDSGFFLRFI RARKFNVGRA YELLRGYVNF
121 RLQYPELFDS LSPEAVRCTI EAGYPGVLSS RDKYGRVVML FNIENWQSQE ITFDEILQAY
181 CFILEKLLEN EETQINGFCI IENFKGFTMQ QAASLRTSDL RKMVDMLQDS FPARFKAIHF
241 IHQPWYFTTT YNVVKPFLKS KLLERVFVHG DDLSGFYQEI DENILPSDFG GTLPKYDGKA
301 VAEQLFGPQA QAENTAFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RLBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 246 nTPM
Expression across tissuesHPA
Tissue
- retina: 246 nTPM
- basal ganglia: 15 nTPM
- choroid plexus: 12 nTPM
- cerebral cortex: 11 nTPM
- amygdala: 9.1 nTPM
- hippocampal formation: 5.7 nTPM
Single-cell type
- müller glia: 2,970 nCPM
- retinal pigment epithelial cells: 2,511 nCPM
- syncytiotrophoblasts: 30 nCPM
- astrocytes: 29 nCPM
- rod photoreceptor cells: 13 nCPM
- retinal horizontal cells: 10 nCPM
Immune cell
- basophil: 0.8 nTPM
- neutrophil: 0.4 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
Brain region
- basal ganglia: 7.1 nTPM
- choroid plexus: 6.8 nTPM
- cerebral cortex: 6.5 nTPM
- hippocampal formation: 4 nTPM
- cerebellum: 3.2 nTPM
- amygdala: 3.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RLBP1.
Disease | AllUniProt
Conditions RLBP1 is implicated in, by any mechanism.
- Bothnia retinal dystrophy (BRD) MIM:607475
- Rod-cone dystrophy Newfoundland (NFRCD) MIM:607476
- Retinitis punctata albescens (RPA) MIM:136880
Disease | GeneticClinVar
52 pathogenic / likely-pathogenic of 424 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Bothnia retinal dystrophy
- Retinitis pigmentosa
- Pigmentary retinal dystrophy
- Newfoundland cone-rod dystrophy
- Retinal dystrophy
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.08
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.31
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RLBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RLBP1 as an antibody target. Whether an autoantibody or antibody against RLBP1 could matter depends on whether native RLBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RLBP1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RLBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...